Strategic legal review of fund offering documents and startup term sheets to help protect your capital, evaluate downside risk, and negotiate investor rights more thoughtfully.
When a startup founder or a fund’s General Partner (GP) presents you with a term sheet, a SAFE, or a Limited Partnership Agreement (LPA), those documents were typically drafted to reflect the issuer’s or sponsor’s interests, not the investor’s. For Limited Partners (LPs), family offices, and angel investors, signing “standard” documents without independent review can leave them with more dilution, fewer information rights, or less flexibility than they expected.
At Ishimbayev Law Firm, we represent the buy-side of private capital. We review offering materials and investment documents from the investor side. Whether you are writing a smaller angel check or making a larger commitment to a fund, we help identify the legal and economic points worth understanding, negotiating, or documenting more carefully.
Reviewing Private Placement Memorandums (PPMs) and LPAs for key issues such as GP catch-up, carried interest alignment, organizational expenses, governance, reporting, and investor rights.
Reviewing SAFEs, convertible notes, and early-stage term sheets with attention to valuation caps, discounts, information rights, pro rata rights, and other terms that can affect the investor’s position over time.
Drafting and negotiating side letters to address MFN elections, fee terms, co-investment rights, reporting, and other investor-specific points where available and commercially realistic.
Providing concise, executive-level summaries of the most critical legal and business risks in a proposed transaction before you commit funds.
We rapidly review the data room, term sheets, and core agreements to map out the economic realities and identify unfavorable legal provisions.
We brief you on the material risks—separating standard market practices from truly aggressive “off-market” terms—and develop a targeted negotiation strategy.
We interface directly with the company’s or fund’s counsel, advocating firmly for your rights while maintaining a collaborative tone to preserve your relationship with the founders or GPs.
Because we work across both issuer-side and investor-side matters, we have a practical sense of which provisions are customary and which ones deserve closer attention from an investor.
We do not look only at legal wording. We also focus on the economic terms that may matter over time, such as pro rata rights, governance rights, fee terms, co-investment opportunities, and information rights where appropriate.
s We try to focus negotiation time on the issues most likely to matter economically or from a governance perspective, rather than creating friction around immaterial points.
We do not bill you for 40-page legal memos that just summarize the contract. We provide sharp, actionable advice: telling you exactly what the risk is, why it matters, and how we plan to fix it in the markup.
SAFEs are widely used and often short-form, but they still require careful review. Issues such as the valuation cap, discount, pro rata rights, MFN provisions, and how the SAFE converts in a priced round can materially affect the investor’s position.
Key areas of concern include “Key Person” clauses (what happens if the star manager leaves?), the definition of the GP’s standard of care (avoiding waivers of fiduciary duty), strict limits on the fund’s ability to recycle capital, and the mechanics of the management fee offsets.
Yes. While a $25k investor may not be able to rewrite a company’s entire operating agreement, they can—and should—negotiate an individual Side Letter securing basic information rights (the right to see quarterly financials) and participation rights in future rounds.
Kindly complete the form provided below
Download our FREE guide and take the
first step in building a successful business